Kinrix FDA Approval History
FDA Approved: Yes (First approved June 24, 2008)
Brand name: Kinrix
Generic name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
Treatment for: Diphtheria Prophylaxis, Tetanus Prophylaxis, Poliomyelitis Prophylaxis, Pertussis Prophylaxis
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.
Development timeline for Kinrix
|Jun 25, 2008||Approval FDA Approves Kinrix - New Combination Vaccine for Children|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.